Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Burning Rock Biotech Ltd ADR (NQ: BNR ) 6.380 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Burning Rock Biotech Ltd ADR < Previous 1 2 3 Next > Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership June 01, 2024 Suzhou MediLink partnered with Germany’s BioNTech to use MediLink’s TMALIN antibody-drug conjugate platform. MediLink will receive an upfront payment of $25 million and up to $1.8 billion in... Via Talk Markets BNR Stock Earnings: Burning Rock Biotech Reported Results for Q1 2024 May 29, 2024 Burning Rock Biotech just reported results for the first quarter of 2024. Via InvestorPlace Three AI Stocks That Are Trading At A Discount In April 2024 April 03, 2024 These AI stocks cover voice, logistics, and videos, and all of them are trading at a decent discount to their real value. Via Talk Markets Topics Artificial Intelligence Exposures Artificial Intelligence BNR Stock Earnings: Burning Rock Biotech Reported Results for Q4 2023 March 28, 2024 Burning Rock Biotech just reported results for the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Monday's After-Market Session March 11, 2024 Via Benzinga Earnings Preview: Burning Rock Biotech March 27, 2023 Via Benzinga Recap: Burning Rock Biotech Q2 Earnings August 31, 2022 Burning Rock Biotech (NASDAQ:BNR) reported its Q2 earnings results on Wednesday, August 31, 2022 at 05:30 AM. Here's what investors need to know about the announcement. Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session February 29, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session December 04, 2023 Via Benzinga Earnings Scheduled For November 30, 2023 November 30, 2023 Companies Reporting Before The Bell • 111 (NASDAQ:YI) is projected to report earnings for its third quarter. • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.45 per share on... Via Benzinga Earnings Scheduled For May 30, 2023 May 30, 2023 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report earnings for its first quarter. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session November 16, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday November 16, 2022 Pre-market stock movers are a hot topic among traders this morning as we cover all of the biggest news moving shares on Wednesday! Via InvestorPlace Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session November 15, 2022 Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split. Via Benzinga Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday's Mid-Day Session September 12, 2022 Gainers Ventyx Biosciences, Inc. (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65. Via Benzinga Livent, Amgen And Some Other Big Stocks Moving Lower On Monday September 12, 2022 U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session September 01, 2022 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session August 31, 2022 Via Benzinga Dow Drops 100 Points; US Crude Oil Inventories Decline Higher-Than-Expected Last Week August 31, 2022 U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 100 points on Wednesday Via Benzinga Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday September 01, 2022 Gainers Via Benzinga Earnings Scheduled For August 31, 2022 August 31, 2022 Companies Reporting Before The Bell • Hywin Holdings (NASDAQ:HYW) is expected to report earnings for its fourth quarter. Via Benzinga Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session August 31, 2022 Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in... Via Benzinga A Preview Of Burning Rock Biotech's Earnings August 30, 2022 Burning Rock Biotech (NASDAQ:BNR) is set to give its latest quarterly earnings report on Wednesday, 2022-08-31. Here's what investors need to know before the announcement. Analysts estimate that... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session August 22, 2022 Via Benzinga Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday August 23, 2022 Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of... Via Benzinga Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday's Mid-Day Session August 22, 2022 Losers Via Benzinga AMC Entertainment, Pharvaris And Some Other Big Stocks Moving Lower On Monday August 22, 2022 Via Benzinga Alibaba, Zoom Video And 76 Biggest Movers From Yesterday July 12, 2022 Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session July 11, 2022 Via Benzinga Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session July 11, 2022 Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.